HR+/HER2- Advanced Breast Cancer Pretreated With Non-Steroid AIsHR+/HER2- Advanced Breast Cancer Pretreated With Non-Steroid AIs

Compare results of trials on endocrine or targeted treatment in HR+/HER2- mBC patients who progressed after a prior NSAI therapy. Future Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news